semaglutide in chronic kidney disease Effects of on CKD Patients With Type 2 Diabetes Add-On, Not Replacement: Semaglutide's Role
Description
A busy science-filled day #ENDO2018 @TheEndoSociety Suggest calibrating your St
Don't forget...
Transform your health and feel rejuvenated with our nutrition-recommended detox drinks and their recipes
A prespecified analysis of the SELECT trial revealed that patients assigned to once-weekly subcutaneous semaglutide 2.4mg lost significantly more weight than those receiving placebo and showed improvements in various anthropometric indices.
A mitochondrial switch ("SLC25A45") controls whether mitochondria burn fat or carbohydrate, and removing it (in mice) makes GLP-1 drugs stop working for fat loss entirely
Plus, how to make it stop.
